By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Orchid Cellmark today reported an 18 percent jump in revenues year over year for the third quarter, led by a boost in its UK business.

For the three months ended Sept. 30, the Princeton N.J.-based DNA testing service firm said revenues totaled $17.3 million, compared to $14.7 million a year ago. In the UK, total revenues increased 44 percent year over year, primarily as a result of a rise in its forensic business there.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

GNC will start using DNA testing to authentic the presence of plants included in its labels, following an agreement with the New York Attorney General.

Fareed Zakaria writes that instead of focusing solely on STEM-related courses, students would do well to pursue the liberal arts if they want to be technology innovators.

A Harvard Business Review study found four major patterns of gender biases and added that black and Latina scientists further had to navigate racial stereotypes.

In PLOS this week: variant linked to canine cleft lip, new compression tool, and more.